Skip to main content

Dextroamphetamine News

FDA Medwatch Alert: FDA Updating Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD and Other Conditions

What safety concern is FDA announcing? To address continuing concerns of misuse, abuse, addiction, and overdose of prescription stimulants, the U.S. Food and Drug Administration (FDA) is requiring...

FDA Approves Xelstrym (dextroamphetamine) Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Miami, FL and Jersey City, NJ - March 23, 2022 --Noven Pharmaceuticals, Inc., awholly-ownedsubsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that the U.S. Food and Drug Administration...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Sexual Dysfunction, SSRI Induced, Attention-Deficit Hyperactivity Disorder (ADHD), Narcolepsy, Fatigue, Drowsiness

Dextroamphetamine patient information at Drugs.com